EXR
42
5
HPQ
55
3
PNW
55
3
DD
44
2
WAT
55
11
PNC
48
6
LRCX
56
4
ES
12
3
AN
49
2
MDLZ
28
2
EQR
33
6
CCI
30
2
L
54
5
SJM
17
5
ROK
46
3
DTE
49
16
AIG
38
5
VNO
46
6
WMT
68
-2
GOOG
77
14
EXR
42
5
HPQ
55
3
PNW
55
3
DD
44
2
WAT
55
11
PNC
48
6
LRCX
56
4
ES
12
3
AN
49
2
MDLZ
28
2
EQR
33
6
CCI
30
2
L
54
5
SJM
17
5
ROK
46
3
DTE
49
16
AIG
38
5
VNO
46
6
WMT
68
-2
GOOG
77
14
Financhill
Back

Generation Bio Quote, Financials, Valuation and Earnings

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
15

GBIO
Generation Bio

Last Price:
$1.19
Seasonality Move:
5.59%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

Generation Bio Price Quote

$1.19

Generation Bio Key Stats

Sell
15
Generation Bio (GBIO) is a Sell
Day range:
$1.06 - $1.21
52-week range:
$0.75 - $4.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.26
P/B ratio:
0.76%
Volume:
884.7K
Avg. volume:
342.1K
1-year change:
-30%
Market cap:
$79.5M
Revenue:
$5.9M
EPS:
$-2.19

How Much Does Generation Bio Make?

Data Unavailable

Is Generation Bio Growing As A Company?

Data Unavailable

Generation Bio Stock Price Performance

  • Did Generation Bio Stock Go Up Last Month?
    Generation Bio share price went down by -11.85% last month
  • Did GBIO's Share Price Rise Over The Last Year?
    GBIO share price fell by -30% over the past 1 year

What Is Generation Bio 52-Week High & Low?

Generation Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Generation Bio?

Data Unavailable

Is Generation Bio Cash Flow Positive?

Data Unavailable

Generation Bio Return On Invested Capital

Data Unavailable

Generation Bio Earnings Date & Stock Price

Generation Bio Competitors

  • Who Are Generation Bio's Competitors?
    Below is a list of companies who compete with Generation Bio or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Codexis Inc (CDXS)
    • CEL-SCI Corp (CVM)
    • OraSure Technologies Inc (OSUR)
    • Relmada Therapeutics Inc (RLMD)

Generation Bio Dividend Yield

Data Unavailable

Generation Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 37.62%
Revenue: 252% 363.4%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 7.50
Upside from Last Price: 530.25%

Major Shareholders

Data Unavailable